Filter By Category
Archives
Share on -
AMCINAFIDE
Generic Name: AMCINAFIDE
ABSTRACT -
Amcinafide, also known as triamcinolone acetophenide, is a synthetic fluorinated glucocorticoid corticosteroid. It has been described as exerting anti-inflammatory and antiallergic properties but was never marketed as an approved medicine.
Its expected pharmacology is consistent with glucocorticoid receptor activation and suppression of inflammatory mediator expression. Published clinical-use information is limited.
DOSAGE -
Dosage should be determined only by a qualified healthcare professional.
No approved human dosing regimen is established for Amcinafide.
The compound should be treated as a research/reference chemical rather than a therapeutic product.
Do not use for self-treatment or outside a regulated study.
SIDE EFFECTS–
Potential corticosteroid-class side effects include:
- Skin irritation, dryness, burning, or itching
- Skin atrophy or striae with prolonged topical exposure
- Acneiform rash or folliculitis
- Delayed wound healing
- HPA-axis suppression with substantial absorption
- Increased blood glucose
- Fluid retention
- Mood changes
- Increased susceptibility to infection
ALLRGIC REACTIONS–
Hypersensitivity to Amcinafide, related triamcinolone derivatives, or excipients is possible.
Symptoms may include:
- Skin rash or hives
- Itching or swelling of the face, lips, tongue, or throat
- Difficulty breathing or chest tightness
- Severe dizziness or fainting
- Unexpected widespread redness, blistering, or peeling skin
Important: Patients who develop an allergic reaction to Amcinafide should seek immediate medical attention and inform all future healthcare providers of the allergy.
DRUG INTERACTIONS–
Specific drug-interaction data are limited. Caution is needed with:
- Other corticosteroids, including topical, inhaled, oral, or injected agents
- Strong CYP3A inhibitors if systemic exposure is possible
- Live vaccines or immunosuppressants
- Antidiabetic medicines in the setting of systemic steroid exposure
- NSAIDs or anticoagulants when systemic corticosteroid effects are expected
Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, and supplements they are using.
PREAUTIONS–
- Do not use on infected or damaged skin unless directed by a clinician.
- Avoid occlusive dressings and large-area exposure unless protocol-defined.
- Monitor endocrine and metabolic effects if systemic absorption is possible.
- Safety in pregnancy, lactation, children, and older adults is not established.
- Use laboratory precautions for handling and disposal.
WARNINGS –
- Amcinafide is not an approved marketed medicine.
- Unsupervised corticosteroid use can mask infection and cause systemic toxicity.
- Avoid ocular exposure because corticosteroids may worsen glaucoma or cataracts.
- Do not use as a substitute for approved dermatologic corticosteroids.
- Keep out of reach of children.
Share on -
. Developed by